Home
Conditions
Duodenal Diseases

Clinical trial condition

Duodenal Diseases

Explore clinical trials studying Duodenal Diseases. Study availability and eligibility vary by location and protocol.

324 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Duodenal Diseases trial results

Completed

H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department

NCT01376414

Conditions: Digestive System Diseases, Duodenal Diseases, Dyspepsia, +13 more
Locations: George Washington University Hospital Washington D.C., District of Columbia, United States

GWU Hospital Washington D.C., District of Columbia, United States

View Trial Details

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

NCT02847455

Conditions: Digestive System Diseases, Duodenal Diseases, Duodenal Ulcer, +4 more
Locations: Not specified

View Trial Details

Completed

Capecitabine and Temozolomide for Neuroendocrine Cancers

NCT00869050

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +32 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Completed

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

NCT01204476

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection

NCT02716025

Conditions: Digestive System Diseases, Duodenal Diseases, Gastrointestinal Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Pharmacodynamics and Safety of CDFR0209

NCT02710994

Conditions: Deglutition Disorders, Digestive System Diseases, Duodenal Diseases, +8 more
Locations: Ajou University Medical Center Suwon, Gyeonggi-do, South Korea

View Trial Details

Completed

Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

NCT02151786

Conditions: Digestive System Diseases, Duodenal Diseases, Duodenal Ulcer, +6 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

NCT00961350

Conditions: Digestive System Diseases, Duodenal Diseases, Gastric Ulcer, +5 more
Locations: Pozen Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

NCT00960869

Conditions: Digestive System Diseases, Duodenal Diseases, Gastric Ulcer, +5 more
Locations: Pozen Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

NCT00995410

Conditions: Aspirin-Associated Gastric Ulcers, Digestive System Diseases, Duodenal Diseases, +5 more
Locations: Pozen Chapel Hill, North Carolina, United States

View Trial Details

Duodenal Diseases

Duodenal Diseases trial results

Related conditions